-
Mashup Score: 0Contemporary Patterns of Local Ablative Therapies for Prostate Cancer at United States Cancer Centers: Results from a National Registry - Beyond the Abstract - 10 month(s) ago
non-muscle invasive bladder cancer (NMIBC), cryoablation, radiofrequency ablation, bladder cancer, focal therapies, local ablative therapy, prostate cancer, renal cancer.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Prevalence of Stone Disease and Procedure Trends in the United States - Beyond the Abstract - 11 month(s) ago
stone disease, Prevalence of Stone Disease and Procedure Trends, ureteroscopy, decreasing shockwave lithotripsy, percutaneous nephrolithotomy, stone disease is increasing in Medicare patients.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Prevalence of #StoneDisease and procedure trends in the #UnitedStates. #BeyondTheAbstract with @endourologyucsd @UCSD_Urology > https://t.co/VSXPRPdwaQ @BEkidneystone @bcutone @urogoldjournal https://t.co/iYpROupgSs
-
-
Mashup Score: 0ASCO 2023: DEAR: Comparative Real-World Evidence on Darolutamide, Enzalutamide, and Apalutamide for Patients with nmCRPC in the United States - 11 month(s) ago
ASCO 2023 DEAR trial prostate cancer, DEAR comparative real-world evidence study of darolutamide, enzalutamide, and apalutamide for patients with nmCRPC in the United States
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
#DEAR Comparative real-world evidence on darolutamide, enzalutamide, and apalutamide for patients with #nmCRPC in the #UnitedStates. Presented by @CaPsurvivorship @DanaFarber. #ASCO23 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/knX2T3V6Kd @ASCO https://t.co/QN832KNiSd
-
-
Mashup Score: 0
ASCO 2023 effectiveness and safety of pembrolizumab plus axitinib versus nivolumab plus ipilimumab in metastatic renal cell carcinoma (RCC) in the United States, CTLA-4 inhibitor/PD-1 inhibitor, metastatic RCC patients.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Head-to-head effectiveness and safety of pembrolizumab + axitinib vs nivolumab + ipilimumab in metastatic #RenalCellCarcinoma in the #UnitedStates. Presentation by @dvir_a @TechnionLive. #ASCO23 written coverage by @RKSayyid @UofT > https://t.co/6jCmX1mdJn @ASCO https://t.co/ON8Q7jdP2s
-
-
Mashup Score: 2
Trends in Prostate Cancer Mortality in the United States of America, WONDER Database, prostate cancer, prostate specific antigen (PSA), prostate cancer mortality rates, PSA screening, prostate cancer mortality rates by race and geography.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Trends in #ProstateCancer mortality in the #UnitedStates, by state and race, from 1999 to 2019: Estimates from the @CDCgov #WONDER database. #BeyondTheAbstract w/ @Jani_Chinmay, @PavlinaChrysafi @MountAuburnHosp, & @DrRanaMcKay @UCSanDiego > https://t.co/MtYn3bLATh @pcan_journal https://t.co/a5vaerdn5u
-
-
Mashup Score: 2Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States - Beyond the Abstract - 11 month(s) ago
prostate cancer imaging, prostate cancer genomic characterization, prostate cancer, racial disparity in prostate cancer, geographic disparity in prostate cancer.positive surgical margins with prostatectomy.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Variation and disparity in the use of #ProstateCancer risk stratification tools in the #UnitedStates. #BeyondTheAbstract with @FolawiyoLaditi and @mleapman @Yale_Urology @YaleMed > https://t.co/eDmsYDUsvV @EurUrolFocus @mleapman https://t.co/2KXapIjPsW
-
-
Mashup Score: 0Demonstrated Underuse of Blue Light Cystoscopy for Bladder Cancer in the United States - Patrick Lewicki - 11 month(s) ago
Ashish Kamat is joined by Patrick Lewicki to discuss the recent publication on the underutilization of Blue Light Cystoscopy (BLC) in the United States. Studying the use of BLC in the Premier Healthcare Database, the findings demonstrate a low level of BLC use despite guideline recommendations and evidence demonstrating the benefit for its use in the management of non-muscle invasive bladder…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Demonstrated underuse of Blue Light Cystoscopy for #BladderCancer in the #UnitedStates. Patrick Lewicki, MD @WeillCornell joins @UroDocAsh @MDAndersonNews to discuss his work in @EurUrolFocus. #WatchNow on UroToday > https://t.co/Ckotr1Gogn @PhotocureASA @Cysview https://t.co/uqmSXEwj2t
-
-
Mashup Score: 0Prevalence of Stone Disease and Procedure Trends in the United States - Beyond the Abstract - 12 month(s) ago
stone disease, Prevalence of Stone Disease and Procedure Trends, ureteroscopy, decreasing shockwave lithotripsy, percutaneous nephrolithotomy, stone disease is increasing in Medicare patients.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Prevalence of #StoneDisease and procedure trends in the #UnitedStates. #BeyondTheAbstract with @endourologyucsd @UCSD_Urology > https://t.co/VSXPRPdwaQ @BEkidneystone @bcutone @urogoldjournal https://t.co/sYt17ZUkTP
-
-
Mashup Score: 0Disparities in Genitourinary Cancers Incidence and Mortality in the United States - Expert Commentary - 12 month(s) ago
financial burden of prostate cancer and bladder cancer, bladder cancer, Genitourinary Cancers, racial disparites in cancer treatment, incidence and mortality of genitourinary cancers.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Disparities in genitourinary cancer incidence and mortality in the #UnitedStates. #ExpertCommentary @FaltasLab @WCMEnglanderIPM discusses work by Schafer et al. in @EUplatinum on UroToday > https://t.co/eLrg3z16zE @AmerCancerCEO @AhJemal @FarhadIslami @TbKratzer_ACS https://t.co/CIVrTa7TBF
-
-
Mashup Score: 2
Price transparency of prostate cancer care in the United States, prostate cancer, prostate specific antigen, prostate magnetic resonance imaging, radical prostatectomy, prostate intensity-modulated radiation therapy, prostate cancer care cost.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Price transparency of #ProstateCancer care in the #UnitedStates: an analysis of pricing and disclosure following the centers for #Medicare and #Medicaid mandate. #BeyondTheAbstract with @AaronMBrant @WeillCornell and @jeshoag @caseccc > https://t.co/NjDqHNadqr @pcan_journal https://t.co/uFezWYgjNx
-
Contemporary patterns of local ablative therapies for #ProstateCancer at #UnitedStates cancer centers: results from a national registry. #BeyondTheAbstract with @M_Koelker @UKEHamburg. #ReadNow on UroToday > https://t.co/kg9vsItJJF @CSPH_BWH @UrolOncol https://t.co/Gwq6DnEPty